Npe4 3

26
To Evaluate the Effectiveness of Medical Nutrition Therapy for Patients with Diabetes Mellitus Angela Tang Dietetic Department United Christian Hospital May 9, 2005

Transcript of Npe4 3

Page 1: Npe4 3

To Evaluate the Effectiveness of

Medical Nutrition Therapyfor Patients with Diabetes Mellitus

Angela TangDietetic Department

United Christian Hospital

May 9, 2005

Page 2: Npe4 3

Medical Nutrition Therapy

♦The use of specific nutrition services to treat an illness, injury, or condition

♦ It involves TWO phases:

1. assessment of nutritional status and thetherapeutic needs of the patient

Definition (ADA, 1994)

2. treatment which includes nutrition therapy,counseling, and the use of nutritionalsupplements

Page 3: Npe4 3

Medical Nutrition Therapy for DM

Major Goals

♦ Achieve & maintain optimal blood glucose & lipid levels through appropriate food choices

♦ Empower persons to self-manage their DM by providing information to increase their knowledge & skills

♦ Provide adequate energy & nutrients for attaining &/or maintaining a reasonable weight for adults

♦ Prevent/delay the long term complications of DM

Page 4: Npe4 3

DCCT & UKPDS

♦Both indicated that tight control of blood glucose can prevent or delay long-term complications of DM

Page 5: Npe4 3

Methods

♦Retrospective study

♦Type 2 DM adult patients

♦Referred by all specialties for MNT

♦Between January 1 and July 31, 2004(for initial consultations)

Page 6: Npe4 3

Medical Nutrition Therapy♦Nutritional Assessment

– Anthropometrics (e.g. BW, BH, BMI)

– Clinical Parameters– Nutrition Knowledge Questionnaire– Diet History

♦Diet Education♦Goal Setting and Meal Plan♦Evaluation

– Dietary Compliance Scoring System – Regular Follow-up

Page 7: Npe4 3

Dietary Compliance Scoring System

♦Balanced Diet♦Portion Control♦Cooking Methods♦Eating-out Choices♦Food Label Recognition♦Alcohol Consumption♦Physical Activities♦Hypoglycemia Recognition & Management

Page 8: Npe4 3

TOTAL 370 patients

(Initial Attendance)

STUDY GROUP

158 patients

attended both 1st and 2nd follow-up

Patients

233 patients

(1st follow-up)

Page 9: Npe4 3

Patients

60%

40%Male

Female

BMI>2384%

18.5<BMI<22.915%

BMI<18.51%

BMI<18.518.5≤BMI≤22.9BMI≥23

Sex Distribution

BMI Distribution

Page 10: Npe4 3

Analyses of Data (paired t test)

Diet Compliance

Clinical Parameters

Follow-upInitial (post-edn)

Initial (pre-edn)

Same day

Body Mass Index (BMI)

Nutrition Knowledge

4 months later

Page 11: Npe4 3

Results – Body Weight

68.6

67.1

66

66.5

67

67.5

68

68.5

69

kg

Initial Follow-up

Comparison of Body Weight

BodyWeight

N = 133p<0.001

Page 12: Npe4 3

Results – Body Mass Index

27.4

26.8

26.4

26.6

26.8

27

27.2

27.4

kg/m2

Initial Follow-up

Comparison of BMI

BMI

N = 133p<0.001

Page 13: Npe4 3

Results – Nutrition Knowledge Score

67.8

83.7

0

10

20

30

40

50

60

70

80

90

%

Pre-edn Post-edn

Comparison of Nutrition Knowledge Score

Nutrition Knowledge Score

p<0.001N = 158

Page 14: Npe4 3

Results – Diet Compliance Score

29.5

44.8

0

10

20

30

40

50

%

Initial Follow-up

Comparison of Diet Compliance Score

Diet ComplianceScore

p<0.001N = 158

Page 15: Npe4 3

Results – Diet Compliance Score

29.6 30.1

44.4 45.3

0

10

20

30

40

50

%

Initial Follow-up

Comparison of Diet Compliance Score

DM Group

Lipid Group

p<0.001

N = 120

N = 141

Diet Control Only/ Static Dosage of Medication

Page 16: Npe4 3

Results – Clinical Outcome Parameters

8.6

7.6

7

7.5

8

8.5

9

mmol/L

Initial Follow-up

Comparison of Fasting Blood Sugar

FBS

p<0.05N = 49

Diet Control Only/ Static Dosage of Medication

Page 17: Npe4 3

Results – Clinical Outcome Parameters

8.5

7.3

6.5

7

7.5

8

8.5

%

Initial Follow-up

Comparison of Glycosylated Haemoglobin

HbA1c

p<0.001N = 43

Diet Control Only/ Static Dosage of Medication

Page 18: Npe4 3

Results – Clinical Outcome Parameters

6.25

3.484.01

5.50

3.033.23

0

1

2

3

4

5

6

7

mmol/L

Initial Follow-up

Comparison of Serum Lipid

TC

TG

LDLC

N=16 p<0.05

N=23 p<0.01

N=8 p=0.589

Diet Control Only/ Static Dosage of Medication

Page 19: Npe4 3

Discussion

Improved Outcomes (Statistically Significant)

♦Body Weight/Body Mass Index

♦Nutrition Knowledge

♦Dietary Compliance

♦Clinical Parameters (FBS, HbA1c, TC & LDLC)

Page 20: Npe4 3

Discussion♦ ↓1.2% in HbA1c

(DCCT: ↓ HbA1c by 2% reduces risk of onset & rate of progression of microvascularcomplications by 60%)

♦ ↓12% in TC & ↓ 19.5% in LDLC(NCEP:↓ TC by 1% reduces risk of coronary heart disease by 2%)

♦ ↓1.5 kg in 4 months – a promising start(ADA:↓ BW by 5-10% enhances insulin

sensitivity and improves blood glucose levels)

Page 21: Npe4 3

Implications

♦The use of Diet Compliance Scoring System and setting small, realistic & attainable goals have proven to be successful for promoting behavioral changes

♦Data collected are also being input into the CMS(RO). This will enhance communication between physicians and dietitians to achieve holistic care for patients

Page 22: Npe4 3

CONCLUSION

MEDICAL NUTRITION THERAPY

Management of DMPrevent/delay onset

of long-term Cx

Nutrition Knowledge

Questionnaire

Diet

Compliance

Anthropometric

Measurements Clinical

Outcome

Markers

EFFECTIVE

Page 23: Npe4 3

Thank you

Page 24: Npe4 3
Page 25: Npe4 3
Page 26: Npe4 3